Course Listing
Advance your knowledge in engaging, interactive courses developed and taught by leaders in the field.
Browse All MDS Courses
New courses are added regularly. If there are not courses listed in the category you are searching, more will be scheduled at a later date. Check back soon or sign up for email notifications.
Please wait while we gather your results.
Medication Adherence in Parkinson's Disease
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.00657 This module will deliver information on medication adherence in Parkinson's disease, aiming towards higher awareness, faster recognition and better management of suboptimal medication adherence. Using the evidence-based approach, we will examine direct and indirect methods commonly used in clinical and research practices to measure medication adherence in Parkinson's disease. Patient centered interventions currently available to promote medication adherence in Parkinson's disease will be discussed. Oscar Gershanik, MD, Cecilia Peralta, MD 60 1.00 2023-05-01 https://education.movementdisorders.org/Detail/657/Medication-Adherence-in-Parkinson's-Disease https://education.movementdisorders.org/Upload/ActivityImages/MedicationAdherence_202x108889503.png 2023-05-01T00:00:00 2026-05-01T00:00:00 <p><span data-contrast="none" data-scheme-color="@000000,," data-usefontface="true" lang="EN-US">This activity is intended for students, residents, primary care providers, internists, allied </span><span data-contrast="none" data-scheme-color="@000000,," data-usefontface="true" lang="EN-US">health, non-neurology specialists, and industry who have limited to no movement </span><span data-contrast="none" data-scheme-color="@000000,," data-usefontface="true" lang="EN-US">disorder experience</span><span data-contrast="none" data-scheme-color="@000000,," data-usefontface="true" lang="EN-US">.</span></p> <p>This MDS Interactive module provides learners with an overview of medication adherence in Parkinson's disease including how to recognize and manage suboptimal medication adherence, methods to measure medication adherence, and patient centered interventions.</p> <p><span style="text-decoration:underline;">Upon completion of this activity learners will be able to:</span></p><p style="margin-left:30px;">1. Define the multidimensional aspects related to medication adherence behaviors in Parkinson's disase.<br>2. Recognize the prevalence, risk factors, screening strategies and reasons for medication adherence failure.<br>3. Discuss the available therapies in Parkinson's disease and the best approach/practical tips to implement tailored interventions to improve adherence in Parkinson's disease.</p> <p>MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.</p> <p><strong>Accreditation Statement</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><strong> </strong></p><p><strong>Credit Designation Statement</strong></p><p>The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 <em>AMA PRA Category 1 Credits™</em>. Physicians should claim only credit commensurate with the extent of their participation in the activity.</p> <p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p> <p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> <p>Oscar Gershanik, MD - Institute of Neuroscience, Favaloro Foundation University Hospital, Beunos Aires, Argentina</p><p>Cecilia Peralta, MD - CEMIC University Hospital, Buenos Aires, Argentina</p> <p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.<br><strong><br>Oscar Gershanik</strong>: <em>Author</em><br>Nothing to Disclose</p><p><br></p><p><strong>Cecilia Peralta</strong>: <em>Author</em></p><p>Consultant: Europharma</p><p>Speaker: Biopas</p><p><br></p><p><strong>Rafael Zuzuarregui: </strong><em>Reviewer</em></p><p>Nothing to Disclose</p><p><br></p> MDS Education <p>Nick Bauman</p> 0 /Courses/Medication-Adherence-in-Parkinsons-Disease1.htm Medication Adherence in Parkinson's Disease 2025-05-27T06:00:41.230 0 0 Foundational / Beginner Clinician Clinician-Primary Care Fellow Health Professional Industry Resident Student Interactive CME On-Demand English USA
Wilson’s Disease: Diagnosis and Management
On Demand
Interactive
60 Minutes
Foundational / Beginner
556 The MDS Wilson's Disease: Diagnosis and Management course will provide a comprehensive overview of Wilson's Disease also known as Hepatolenticular Degeneration including genetics and pathophysiology, clinical manifestations, diagnostic procedures, and clinical management of the disease. John K. Fink, MD 60 0.00 2022-04-29 https://education.movementdisorders.org/Detail/556/Wilson’s-Disease:-Diagnosis-and-Management https://education.movementdisorders.org/Upload/ActivityImages/Kayser-Fleischer_ringArrowcroppedresized144229.jpg 2022-04-29T00:00:00 2028-04-29T00:00:00 MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>John K. Fink, MD - Department of Neurology, University of Michigan, Ann Arbor, MI, USA</p><p>Matthew Lorincz, MD, PhD - Department of Neurology, University of Michigan, Ann Arbor, MI, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Describe the genetics and pathophysiology of Wilson’s disease.<br>2. Recognize the clinical manifestations and types of ancillary investigations in Wilson’s disease.<br>3. Discuss the management of Wilson’s disease.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This module is intended for neurologists, primary care physicians with an interest in movement disorders, neurology residents and movement disorder fellows.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Wilsons-Disease-Diagnosis-and-Management1.htm Wilson’s Disease: Diagnosis and Management 2025-05-27T06:00:39.137 0 0 Foundational / Beginner Clinician Student Interactive On-Demand English USA
Autoimmune Movement Disorders: Five Illustrative Cases
On Demand
Interactive
60 Minutes
Foundational / Beginner
496 The MDS Autoimmune Movement Disorders: Five Illustrative Cases course will provide a comprehensive overview of a step-by-step approach to diagnosis and management of autoimmune movement disorders. Andrew McKeon, MB, BCh, MD 60 0.00 2021-11-17 https://education.movementdisorders.org/Detail/496/Autoimmune-Movement-Disorders:-Five-Illustrative-Cases https://education.movementdisorders.org/Upload/ActivityImages/Autoimmune-Movement-Disorders_-Five-Illustrative-Cases132074.jpg 2021-11-17T00:00:00 2027-11-17T00:00:00 MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Andrew McKeon, MB, BCh, MD - Mayo Clinic, Rochester, MN, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>1. Recognize the clinical features of autoimmune-mediated movement disorders using illustrative cases.<br>2. Discuss the diagnostic approach, including laboratory, imaging, specific antibodies and other tests.<br>3. Describe the treatment options available.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Autoimmune-Movement-Disorders-Five-Illustrative-Cases1.htm Autoimmune Movement Disorders: Five Illustrative Cases 2025-05-27T06:00:31.530 0 0 Foundational / Beginner Clinician Resident Student Interactive On-Demand English USA
Clinical Case Presentation: A Patient with Suspected Functional Gait
On Demand
Interactive
60 Minutes
Foundational / Beginner
443 The MDS Clinical Case Presentation: A Patient with Suspected Functional Gait course will provide a comprehensive overview of patient history and examination aspects that suggest functional gait disorder. Xin Xin Yu, MD 60 0.00 2021-07-20 https://education.movementdisorders.org/Detail/443/-Clinical-Case-Presentation:-A-Patient-with-Suspected-Functional-Gait https://education.movementdisorders.org/Upload/ActivityImages/Clinical-Case-Presentation_-A-Patient-with-Suspected-Functional-Gait521973.jpg 2021-07-20T00:00:00 2027-07-20T00:00:00 MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Xin Xin Yu, MD - Neurological Institute’s Center for Neurological Restoration at Cleveland, Ohio, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Identify aspects of the history and examination that suggest functional gait disorder.</p><p>2. Explain a functional gait disorder diagnosis to patients.</p><p>3. Discuss therapeutic options for functional gait disorders.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Clinical-Case-Presentation-A-Patient-with-Suspected-Functional-Gait.htm Clinical Case Presentation: A Patient with Suspected Functional Gait 2025-05-27T06:00:29.827 0 0 Foundational / Beginner Clinician Health Professional Interactive On-Demand English USA
Use of Botulinum Toxin for Cervical Dystonia
On Demand
Interactive
60 Minutes
Experienced / Intermediate
143 The MDS Botulinum Toxin for Cervical Dystonia course will provide a comprehensive overview of treating cervical dystonia with botulinum neurotoxin injections in combination with EMG and ultrasound. Alberto Albanese, MD ; Anna Castagna, MD 60 0.00 2021-02-01 https://education.movementdisorders.org/Detail/143/Use-of-Botulinum-Toxin-for-Cervical-Dystonia https://education.movementdisorders.org/Upload/ActivityImages/Use-of-Botulinum-Toxin-for-Cervical-Dystonia394289.jpg 2021-02-01T00:00:00 2027-02-01T00:00:00 <p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p> <p>The primary purpose of this course is to provide information on the use of botulinum toxin for cervical dystonia.</p> <p>Upon completion of this activity learners will be able to:</p><p>1. Analyze movements in order to select muscles for botulinum toxin injection in the most common cervical dystonias (anterocollis, retrocollis, laterocollis and torticollis)</p><p>2. Identify the different botulinum toxin formulations and doses in order to choose the appropriate toxin for a patient and describe the techniques needed to prepare the toxin</p><p>3. Discuss the methods of injection (EMG, palpation/anatomical landmarks, ultrasound) for cervical dystonia and possible adverse effects from injection</p> <p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher)</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> <p>Alberto Albanese, MD - Università Cattolica del Sacro Cuore, Rozzano MI, Italy</p><p>Anna Castagna, MD - IRCCS Fondazione Don Carlo Gnocchi, Milano, Italy</p> MDS Education <p>Ericka Blackford</p> 0 /Courses/Use-of-Botulinum-Toxin-for-Cervical-Dystonia.htm Use of Botulinum Toxin for Cervical Dystonia 2025-05-27T06:00:17.497 0 0 Experienced / Intermediate Clinician Interactive On-Demand English
Genetic Testing 101 Part B
On Demand
Interactive
60 Minutes
Experienced / Intermediate
CME Credits:1.00142 The MDS Genetic Testing 101 (Part B) course will provide a comprehensive overview of genetic testing. Henry Houlden ; Viorica Chelban, MD 60 1.00 2020-09-03 https://education.movementdisorders.org/Detail/142/Genetic-Testing-101-Part-B https://education.movementdisorders.org/Upload/ActivityImages/GeneticTestingAB.jpg 2020-09-03T00:00:00 2026-09-03T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/GeneticTestingB-Discl_28082024111625.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Henry Houlden - UCL Institute of Neurology, London, United Kingdom</p><p>Viorica Chelban, MD - University College London, London, United Kingdom</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Describe what genetic testing is, how it can be obtained, how results can be interpreted, and the limitations of the various available methods.</p><p>2. Recognize when and what type of genetic testing should be performed for a patient with a movement disorder.</p><p>3. Discuss the important ethical issues and principles involved in genetic testing and counseling.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Genetic-Testing-101-Part-B.htm Genetic Testing 101 Part B 2025-05-27T06:00:16.683 0 0 Experienced / Intermediate Clinician Fellow Interactive CME On-Demand English
Genetic Testing 101 Part A
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.00141 The MDS Genetic Testing 101 (Part A) course will provide a comprehensive overview of genetic testing. Henry Houlden ; Viorica Chelban, MD 60 1.00 2020-09-03 https://education.movementdisorders.org/Detail/141/Genetic-Testing-101-Part-A https://education.movementdisorders.org/Upload/ActivityImages/GeneticTestingAB.jpg 2020-09-03T00:00:00 2026-09-03T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/GeneticTestingA-Discl_28082024110821.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Henry Houlden - UCL Institute of Neurology, London, United Kingdom</p><p>Viorica Chelban, MD - University College London, London, United Kingdom</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Describe what genetic testing is, how it can be obtained, how results can be interpreted, and the limitations of the various available methods.</p><p>2. Recognize when and what type of genetic testing should be performed for a patient with a movement disorder.</p><p>3. Discuss the important ethical issues and principles involved in genetic testing and counseling.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Genetic-Testing-101-Part-A.htm Genetic Testing 101 Part A 2025-05-27T06:00:14.293 0 0 Foundational / Beginner Clinician Fellow Interactive CME On-Demand English
Approach and Management of Neuropsychiatric Issues in Parkinson’s Disease
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.00919 This module will provide up-to-date knowledge of key neuropsychiatric features of movement disorders including practical guidelines, assessment tools for diagnosis and evidence-based treatments. Additionally, the module will discuss state-of-the-art care for the complex needs of our patients with movement disorders. Lana Chahine, MD; Daniel Weintraub, MD; Bart Swinnen, MD, PhD 60 1.00 2025-03-17 https://education.movementdisorders.org/Detail/919/Approach-and-Management-of-Neuropsychiatric-Issues-in-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/05INTERACT-41-001-Neuropsychiatric-Issues-in-PD-202x108821930.jpg 2025-03-17T00:00:00 2028-03-17T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Disclosures - Neuropsychiatric Issues in PD_03032025030439.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Lana Chahine, MD - University of Pittsburgh, Pittsburgh, PA, USA</p><p>Daniel Weintraub, MD - University of Pennsylvania, Philadelphia, PA, USA</p><p>Bart Swinnen, MD, PhD - UCSF, San Francisco, CA, USA</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Recognize the range of key neuropsychiatric features of movement disorders.</p><p>2. Learn how to assess and diagnose neuropsychiatric disorders in movement disorders.</p><p>3. Implement an evidence-based treatment plan for neuropsychiatric features of movement disorders.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Approach-and-Management-of-Neuropsychiatric-Issues-in-Parkinsons-Disease.htm Approach and Management of Neuropsychiatric Issues in Parkinson’s Disease 2025-03-17T00:01:37.670 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Interactive CME On-Demand English USA
Neuroimaging in Parkinsonian Syndromes
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.00903 This module will discuss the characteristics of each imaging technique and the imaging findings related to parkinsonian syndromes. Before starting this module, the audience is recommended to understand key clinical features of parkinsonian syndromes and their relevant pathological locations. Elie Matar, MD, PhD 60 1.00 2025-01-15 https://education.movementdisorders.org/Detail/903/Neuroimaging-in-Parkinsonian-Syndromes https://education.movementdisorders.org/Upload/ActivityImages/Neuroimaging-in-Parkinsonian-Syndromes151395.jpg 2025-01-15T00:00:00 2028-01-15T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a class="fr-file" href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/NIMD - Disclosures_11122024020550.pdf" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Elie Matar, MD, PhD - University of Sydney / University College London, Sydney, Australia</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to: </p><p>1. Understand the characteristics of each imaging technique.</p><p>2. Learn the conventional imaging findings specific to the common parkinsonian syndromes and mimics.</p><p>3. Develop awareness of application of additional neuroimaging modalities and analytical tools as emerging biomarkers in the field.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Neuroimaging-in-Parkinsonian-Syndromes.htm Neuroimaging in Parkinsonian Syndromes 2025-01-15T00:01:23.033 0 0 Foundational / Beginner Clinician Fellow Industry Resident Student Interactive CME On-Demand English USA
Cell Models of Parkinson’s Disease
On Demand
Interactive
60 Minutes
Foundational / Beginner
CME Credits:1.00663 The Cell Models of Parkinson's Disease module provides an introductory course on cellular models of Parkinson’s disease, their strengths and limitations, their use in experimental and pre-clinical applications and how to critically interpret findings in research and translational contexts. Tiago Outeiro, PhD 60 1.00 2024-12-09 https://education.movementdisorders.org/Detail/663/Cell-Models-of-Parkinson’s-Disease https://education.movementdisorders.org/Upload/ActivityImages/Cell-Models_202x108161054.png 2024-12-09T00:00:00 2027-12-09T00:00:00 <p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits™</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty%20Disclosures%20-%20Cell%20Models%20of%20PD_21082024014214.pdf" rel="noopener noreferrer" target="_blank">HERE.</a> All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>METHOD OF PARTICIPATION </strong></p><p>Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p> MDS Education <p><span style="background-color: null;"><strong>FACULTY</strong></span></p><p>Tiago Outeiro, PhD - University Medical Center Goettingen, Goettingen, Germany</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Discuss cell models of Parkinson’s disease and their pathological basis.<br>2. Define the strengths and limitations of Parkinson’s disease cell models and contextualize their extrapolability.<br>3. Outline the use of Parkinson’s disease cell models in experimental and pre-clinical settings and how to critically interpret findings.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p><span data-contrast="auto" lang="EN-US">This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.</span><span data-ccp-props='{"201341983":0,"335559740":259}'> </span></p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p> 0 /Courses/Cell-Models-of-Parkinsons-Disease.htm Cell Models of Parkinson’s Disease 2024-12-09T15:00:47.957 0 0 Foundational / Beginner Clinician Clinician-Primary Care Fellow Industry Resident Student Interactive CME On-Demand English USA